SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after securing a non-exclusive licensing agreement with Pfizer for its Matrix-M adjuvant, a deal seen by many as a significant validation of its platform technology across potential new disease areas. The community is actively discussing the potential for upfront payments, substantial milestones, and royalties, while also looking for further partnerships, particularly for its advanced COVID-Flu combination vaccine. This recent strategic move, alongside the company's strengthened financial position, is generating optimism about future growth despite ongoing activist investor pressure.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media (DJT) is trending as discussions erupt over former President Trump's threats of new tariffs on European nations, stemming from their stance on Greenland and his apparent frustrations regarding the Nobel Peace Prize. This has ignited heated debate among the community, with many expressing concern over potential market instability and strained international relations, while supporters view these actions as beneficial for "America First" economic policies.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is seeing heightened volatility as President Trump's escalating tariff threats against NATO allies, particularly concerning Greenland, spark widespread geopolitical uncertainty. Community sentiment is sharply divided, with some anticipating a deeper market correction while others view the current downturn as a 'buy the dip' opportunity amidst global bond market concerns and a notable rise in precious metal prices. Investors are closely monitoring a potential Supreme Court ruling on tariffs as a key market mover.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community closely follows its ongoing interactions with the FDA regarding the Biologics License Application for its Duchenne muscular dystrophy treatment, deramiocel, and the forthcoming submission of the full HOPE-3 clinical study report. Sentiment is divided, with many expressing strong bullishness and anticipating significant upside potential, while others voice concerns over perceived delays and discuss potential market manipulation, as analysts reiterate positive ratings for the company.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to highly positive Phase 1 clinical trial results for its drug, soquelitinib, in treating moderate to severe atopic dermatitis. This early data, especially in patients resistant to other treatments, is fueling community excitement about its potential as a significant new option in a large market, with discussions also revolving around the possibility of strategic partnerships or a buyout, alongside concerns about the drug's early development stage.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is experiencing significant volatility amid escalating geopolitical tensions, notably the US asserting control over Venezuela's oil and ongoing debates surrounding US tariffs, fueling a "flight to quality" narrative for some. The community is actively discussing whether these events, alongside large institutional bond purchases, will continue to boost Treasuries as a safe haven or intensify concerns over US debt and the Federal Reserve's independence.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending due to regulatory clarity for ANKTIVA's resubmission for papillary bladder cancer, requiring no new clinical trials, coupled with expanding international approvals. The community is actively discussing the potential for a significant short squeeze, driven by high short interest and exceptional volume, as many investors embrace the long-term "cancer cure" narrative. This optimism persists even as the broader market faces headwinds, highlighting IBRX's standout performance and promising pipeline.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is experiencing significant volatility and trending discussions following a critical report alleging financial misconduct, compounded by broader weakness in the tech sector. While many in the community are dismissing the report as rehashed FUD and market manipulation, bulls are highlighting the company's strong AI-powered ad platform and anticipated robust Q4 earnings. This has fueled a sharp debate between those buying the dip and bears reacting to the serious claims, driving notable price swings.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is currently experiencing a significant surge, fueled by an intense Arctic air invasion across the United States that is driving up natural gas demand and futures prices. The strong upward momentum has triggered a notable short squeeze, with the community actively discussing substantial profits and anticipating continued upside as extreme cold weather is projected to persist. This volatility is characteristic of the 2x leveraged ETF, attracting both profit-takers and those eyeing further gains.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

Top Wealth Group Holding Ltd. is currently trending due to news of a strategic acquisition and a recent public offering that sparked extreme volatility. The community is sharply divided between anticipating massive upside driven by its low float and projected profitability, and expressing caution over its significant price swings. Traders are actively debating if this presents a compelling buying opportunity or a cautionary tale, drawing parallels to other high-momentum low-float stocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bombardier continues climb as RBC raises PT, sees more upside

Investing.com -- Shares of   Bombardier Inc   (TSX:BBDb) soared 3% on Monday, lifting the stock to its highest level since 2011, after RBC (TSX:RY) Capital Markets increased its price target on the business jet manufacturer to C$175 from C$108. The call reflects growing investor confidence in the company’s long-term free cash flow potential and valuation re-rating despite near-term earnings remaining below Street estimates.

Bombardier’s U.S. shares (BDRBF) reached their highest level since January 2014 on Wednesday as Wall Street analysts lauded the Canadian business jet maker securing orders for 50 aircraft valued at $1.7 billion.On Monday, Bombardier said an undisclosed customer will purchase its Challenger and Global series of aircraft, holding options to acquire 70 more, bringing the total deal value to $4 billion if all the planes are purchased. The deliveries of the business jets, used by both government and private entities, are scheduled to begin in 2027.In May, the company said it expects to deliver more than 150 aircraft in 2025. It is ramping up operations globally, with service centers and other facilities set to open in the United Arab Emirates, the UK, and Australia.Its Toronto-listed shares also jumped on Wednesday. Canadian markets were closed on July 1 for the Canada Day holiday.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/BDRBF">Bombardier</a> was in the ‘bullish’ while retail chatter was ‘extremely high.’“I can see it reaching 120s to even 130s if it keeps this up,” one user said.<stembedurl>https://stocktwits.com/ScreamingEagles/message/619727892</stembedurl>&nbsp;&nbsp;According to TheFly, Scotiabank upgraded Toronto-listed shares of Bombardier to ‘Outperform’ from ‘Sector Perform’ and noted that demand is seemingly rebounding with the tariff noise dissipating. The brokerage also reportedly said that Bombardier is "firing on all cylinders after a lacklustre Q1 order intake."According to a Bloomberg report, TD Cowen analyst Tim James noted airplane orders of similar scale is not common and it could aide in building investor confidence once more and lead to a stock re-rating.Bombardier’s U.S. shares have gained 58.5% this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/robinhood-stock-dips-after-open-ai-denies-links-to-tokenized-offering/chFjLIURcLf">Robinhood Stock Dips After OpenAI Denies Links To Tokenized Offering: 'We... Do Not Endorse It'</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bombardier Challenger 604, from private company, preparing for take off on the Barcelona airport runway, in Barcelona, Spain, on March 5, 2025. 

Bombardier Stock Rockets To Over 11-Year High As Analysts Cheer $1.7B Jet Order: ‘Firing On All Cylinders’

The aircraft maker stated earlier this week that the buyer also has options to buy 70 more aircraft.

Bombardier Stock Rockets To Over 11-Year High As Analysts Cheer $1.7B Jet Order

Equity

Bombardier’s (BDRAF) U.S.-shares rose 2.2% in extended trading on Monday after the Canadian firm said it has received orders for 50 aircraft, alongside a service agreement, valued at $1.7 billion.The aircraft maker stated that an undisclosed customer will purchase the Challenger and Global series of aircraft, holding options to acquire 70 more, bringing the total deal value to $4 billion if all the planes are purchased. The deliveries of business jets, used by both government and private entities, are scheduled to begin in 2027.“This significant order underscores the competitive advantage Bombardier’s full scope of products and services brings to customers throughout the entire aircraft lifecycle, from design to delivery, then throughout the in-service journey,” said CEO Éric Martel in a statement.In May, the company said it expects to deliver more than 150 aircraft in 2025. It is ramping up operations globally, with service centers and other facilities set to open in the United Arab Emirates, the UK, and Australia.However, the company will look forward to a trade deal between Canada and the U.S. to mitigate tariff uncertainty.Retail sentiment on Stocktwits was in the ‘neutral’ (50/100) territory, while retail chatter was ‘normal.’“The company is well-positioned in the large and medium cabin business jet categories, with its flagship Global and Challenger series aircraft experiencing strong order demand. In particular, we consider its Global series best-in-class in the ultra-long-range jet market,” S&amp;P Global analysts said in June before upgrading the company’s credit rating.The rating agency also projected annual adjusted core profit growth to average in the high-single-digit percentage points over the next three years.<a href="https://stocktwits.com/symbol/BDRAF">Bombardier’s U.S. shares</a> have risen nearly 25% this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/aero-vironment-stock-slips-after-1-35-b-capital-raise-plan-to-bolster-drone-manufacturing/chFgCpzRR1F">AeroVironment Stock Slips After $1.35B Capital Raise Plan To Bolster Drone Manufacturing</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bombardier Challenger 604, from TAG Aviation Malta company, preparing for take off on the Barcelona airport runway, in Barcelona, Spain, on March 5, 2025.

Bombardier Scores $1.7B Contract Win For Business Jets, Services

Bombardier’s (BDRAF) U.S.-shares rose 2.2% in extended trading on Monday after the Canadian firm said it has received orders for 50 aircraft, alongside a service agreement, valued at $1.7 billion.

The business jet deliveries are scheduled to begin in 2027.

Bombardier, Inc. engages in the design, building, and maintenance of aircraft. It operates through the Business Aircraft and Others segments. The Business Aircraft segment is involved in selling new aircraft, pre-owned aircraft, and defense aircraft, as well as services and support including parts, smart services, service centers, training, and technical publications. The Others segment refers to the sale of components related to commercial aircraft programs. The company was founded on June 19, 1902 and is headquartered in Dorval, Canada.

Current Price	$195.70
Prev Close	$188.64
Open	$195.47
Dividend Yield	0.00%
50-Day Moving Average	$162.79
Beta	0.61
Avg. Volume	247.86
PE Ratio	46.48

52-Week High	$195.74
52-Week Low	$53.38
Market Capitalization	$19.61B
EPS (Annual)	$3.45
Price to Book	-10.19
Revenue Per Employee	$460,904.26
Enterprise Value/EBITDA	N/A

BDRAF
Bombardier Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BDRAF News

BDRAFBombardier Inc. - Ordinary Shares - Class A